These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20185137)

  • 1. Drug release from coronary eluting stents: A multidomain approach.
    Vairo G; Cioffi M; Cottone R; Dubini G; Migliavacca F
    J Biomech; 2010 May; 43(8):1580-9. PubMed ID: 20185137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling drug elution from stents: effects of reversible binding in the vascular wall and degradable polymeric matrix.
    Borghi A; Foa E; Balossino R; Migliavacca F; Dubini G
    Comput Methods Biomech Biomed Engin; 2008 Aug; 11(4):367-77. PubMed ID: 18568831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion and drug elution model of a coronary stent.
    Migliavacca F; Gervaso F; Prosi M; Zunino P; Minisini S; Formaggia L; Dubini G
    Comput Methods Biomech Biomed Engin; 2007 Feb; 10(1):63-73. PubMed ID: 18651272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
    Ahmed WH
    Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some aspects of drug eluting stents.
    Kathuria YP
    Int J Cardiol; 2007 Jul; 119(3):380-3. PubMed ID: 17067691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular stent design and vessel stresses: a finite element analysis.
    Lally C; Dolan F; Prendergast PJ
    J Biomech; 2005 Aug; 38(8):1574-81. PubMed ID: 15958213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects.
    Li JJ; Li J; Nan JL; Li Z; Zhen X; Mu CW; Dai J; Zhang CY
    Med Hypotheses; 2007; 69(5):1004-9. PubMed ID: 17499449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel simulation strategy for stent insertion and deployment in curved coronary bifurcations: comparison of three drug-eluting stents.
    Mortier P; Holzapfel GA; De Beule M; Van Loo D; Taeymans Y; Segers P; Verdonck P; Verhegghe B
    Ann Biomed Eng; 2010 Jan; 38(1):88-99. PubMed ID: 19898936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geometry parameterization and multidisciplinary constrained optimization of coronary stents.
    Pant S; Bressloff NW; Limbert G
    Biomech Model Mechanobiol; 2012 Jan; 11(1-2):61-82. PubMed ID: 21373889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stainless and shape memory alloy coronary stents: a computational study on the interaction with the vascular wall.
    Migliavacca F; Petrini L; Massarotti P; Schievano S; Auricchio F; Dubini G
    Biomech Model Mechanobiol; 2004 Jun; 2(4):205-17. PubMed ID: 15029511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulation of a balloon expandable stent in a realistic coronary artery-Determination of the optimum modelling strategy.
    Zahedmanesh H; John Kelly D; Lally C
    J Biomech; 2010 Aug; 43(11):2126-32. PubMed ID: 20452594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of tissue prolapse after balloon-expandable stenting: influence of stent cell geometry.
    Capelli C; Gervaso F; Petrini L; Dubini G; Migliavacca F
    Med Eng Phys; 2009 May; 31(4):441-7. PubMed ID: 19109049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiobjective design optimisation of coronary stents.
    Pant S; Limbert G; Curzen NP; Bressloff NW
    Biomaterials; 2011 Nov; 32(31):7755-73. PubMed ID: 21821283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing pulsatile flow in a deployed coronary stent.
    Rajamohan D; Banerjee RK; Back LH; Ibrahim AA; Jog MA
    J Biomech Eng; 2006 Jun; 128(3):347-59. PubMed ID: 16706584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting bioabsorbable magnesium stent.
    Di Mario C; Griffiths H; Goktekin O; Peeters N; Verbist J; Bosiers M; Deloose K; Heublein B; Rohde R; Kasese V; Ilsley C; Erbel R
    J Interv Cardiol; 2004 Dec; 17(6):391-5. PubMed ID: 15546291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-eluting stents do they make the difference? ].
    Presbitero P; Asioli M
    Minerva Cardioangiol; 2002 Oct; 50(5):431-42. PubMed ID: 12384625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.